Skip to main content
28 September 2023
Last updated: Wednesday 27 September 2023
User account anon menu
Login
Register and subscribe
Search
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form
Menu
Breadcrumb
Home
Cancer (Oncology)
Cancer (Oncology)
ASCO 2023 Strong data for lung and breast cancer drugs
Read more
New opportunities for small molecules in cancer
Read more
Development timelines for new oncology drugs
Read more
FDA guides on accelerated approvals in oncology
Read more
Oncology pipeline marked by multiple therapy types
Read more
Immunocore and Gadeta probe gamma delta T cell receptors
Read more
Novel oncology drugs approved in a year of change
Read more
Progressive increase in oncology drug approvals
Read more
Checkpoint inhibitors are focus at ESMO
Read more
Microbiome-based therapies as anti-cancer agents
Read more
Pagination
Page 1
Next page
››
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form